Skip to main content

1 Result(s)

within M. Bruweleit Remove this filter

and

  1. No Access

    Article

    Phase II trial of vinorelbine and trastuzumab in patients with HER2-positive metastatic breast cancer. A prospective, open label, non-controlled, multicenter phase II trial (to investigate efficacy and safety of this combination chemotherapy)

    The purpose of this study was to evaluate the efficacy (progression free survival (PFS) and response rate) and safety of vinorelbine and trastuzumab combination chemotherapy in patients with HER2-overexpressin...

    G. Schilling, M. Bruweleit, N. Harbeck, C. Thomssen, K. Becker… in Investigational New Drugs (2009)